CN Stock MarketDetailed Quotes

301367 BMC Medical

Watchlist
  • 71.44
  • +3.13+4.58%
Market Closed Nov 19 15:00 CST
6.40BMarket Cap42.12P/E (TTM)

BMC Medical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-36.31%602.08M
-48.79%382.17M
-60.02%192.09M
-20.70%1.12B
-6.81%945.3M
32.58%746.29M
131.85%480.44M
113.64%1.42B
123.64%1.01B
106.31%562.9M
Operating revenue
-36.31%602.08M
-48.79%382.17M
-60.02%192.09M
-20.70%1.12B
-6.81%945.3M
32.58%746.29M
131.85%480.44M
113.64%1.42B
123.64%1.01B
106.31%562.9M
Other operating revenue
----
-39.23%667.27K
----
14.87%3.01M
----
22.43%1.1M
----
84.66%2.62M
----
344.78%896.89K
Total operating cost
-28.75%507.04M
-39.37%317.01M
-51.79%149M
-15.03%870.69M
-2.12%711.63M
29.99%522.86M
104.41%309.05M
94.67%1.02B
115.94%727.03M
97.40%402.22M
Operating cost
-42.13%293.84M
-54.12%184.57M
-63.59%92.69M
-26.82%604.52M
-16.67%507.73M
21.80%402.26M
112.62%254.54M
119.70%826.09M
155.44%609.29M
135.54%330.26M
Operating tax surcharges
23.67%6.8M
-60.40%1.84M
-82.46%612.12K
-25.60%6.43M
-1.64%5.5M
73.95%4.66M
361.29%3.49M
114.45%8.64M
56.57%5.59M
0.72%2.68M
Operating expense
1.65%77.97M
3.64%48.41M
2.96%20.72M
24.55%106.61M
34.72%76.7M
36.32%46.71M
45.57%20.13M
22.06%85.59M
21.78%56.93M
18.05%34.27M
Administration expense
33.72%43.29M
57.38%30.18M
33.17%11.45M
-16.35%40.28M
30.98%32.37M
24.57%19.18M
72.34%8.59M
79.06%48.15M
38.89%24.72M
27.58%15.4M
Financial expense
-38.93%-5.5M
-12.77%-6.15M
-157.90%-1.6M
75.19%-4.11M
68.59%-3.96M
-13.70%-5.46M
233.95%2.76M
-1,631.63%-16.58M
-1,953.29%-12.61M
-763.44%-4.8M
-Interest expense (Financial expense)
122.35%2.32M
-17.92%587.36K
-18.19%292.89K
192.57%1.36M
195.13%1.04M
527.67%715.63K
759.50%358.02K
135.82%463.67K
136.48%353.6K
8.98%114.01K
-Interest Income (Financial expense)
-91.46%-7.13M
-87.56%-4.72M
-10.25%-1.48M
-16.09%-6.18M
-163.74%-3.73M
-179.80%-2.52M
-451.24%-1.34M
-72.14%-5.33M
43.94%-1.41M
51.65%-898.98K
Research and development
-2.84%90.64M
4.75%58.15M
28.63%25.13M
60.54%116.98M
116.44%93.29M
127.34%55.51M
76.35%19.54M
50.92%72.86M
40.64%43.1M
20.01%24.42M
Credit Impairment Loss
33.83%-1.82M
134.08%769.24K
76.98%-475.48K
39.31%-2.29M
17.01%-2.75M
-176.10%-2.26M
-132.73%-2.07M
-1,477.15%-3.77M
-1,441.39%-3.31M
-280.71%-817.61K
Asset Impairment Loss
---876.46K
---854.4K
----
---10.23M
----
----
----
--0
----
----
Other net revenue
-31.59%51.52M
-33.91%37.8M
2.99%12.59M
90.53%86.08M
224.94%75.32M
287.34%57.2M
148.88%12.23M
61.86%45.18M
19.02%23.18M
26.08%14.77M
Fair value change income
--1.95M
--118K
--118K
----
----
----
----
----
----
----
Invest income
-1.88%39.11M
-13.65%26.01M
-39.75%6.28M
287.23%57.17M
351.91%39.86M
350.21%30.12M
259.70%10.42M
74.45%14.76M
50.33%8.82M
79.45%6.69M
-Including: Investment income associates
----
-7.21%-173.88K
-3.25%-246.11K
-111.55%-304.26K
-106.57%-172.99K
-109.75%-162.18K
-143.98%-238.35K
13.88%2.63M
--2.63M
29.36%1.66M
Asset deal income
-58.13%199.81K
-53.33%203.52K
-155.09%-37.86K
2,206.59%477.21K
2,206.59%477.21K
3,380.57%436.11K
--68.73K
--20.69K
--20.69K
--12.53K
Other revenue
-65.67%12.95M
-60.02%11.56M
76.31%6.71M
19.86%40.95M
113.77%37.73M
225.39%28.9M
31.07%3.81M
73.54%34.17M
27.68%17.65M
8.33%8.88M
Operating profit
-52.57%146.57M
-63.31%102.96M
-69.68%55.67M
-22.48%337.81M
-0.51%308.99M
59.96%280.63M
201.32%183.62M
165.72%435.79M
127.70%310.58M
117.12%175.44M
Add:Non operating Income
200.04%173.95K
-72.41%15.9K
-77.62%12.9K
-85.00%107.43K
-91.11%57.97K
-91.16%57.64K
-72.69%57.64K
718.40%716.11K
2,269.00%651.8K
61,982.49%651.8K
Less:Non operating expense
-43.26%1.82M
-88.52%348.31K
-97.79%54.21K
174.42%3.88M
471.84%3.21M
455.12%3.03M
1,742.59%2.46M
522.00%1.42M
901.13%561.51K
170,826,156.25%546.64K
Total profit
-52.62%144.92M
-63.04%102.63M
-69.30%55.63M
-23.23%334.03M
-1.56%305.83M
58.16%277.66M
197.00%181.22M
165.52%435.09M
127.81%310.67M
117.25%175.55M
Less:Income tax cost
-46.84%17.37M
-72.17%8.9M
-79.15%5.08M
-36.74%34.2M
-20.24%32.68M
38.98%31.99M
212.74%24.36M
197.33%54.06M
132.64%40.97M
138.98%23.02M
Net profit
-53.31%127.55M
-61.85%93.72M
-67.77%50.55M
-21.31%299.83M
1.28%273.15M
61.06%245.66M
194.70%156.87M
161.55%381.03M
127.10%269.7M
114.31%152.53M
Net profit from continuing operation
-53.31%127.55M
-61.85%93.72M
-67.77%50.55M
-21.31%299.83M
1.28%273.15M
61.06%245.66M
194.70%156.87M
161.55%381.03M
127.10%269.7M
114.31%152.53M
Net income from discontinuing operating
----
----
----
----
----
--0
----
----
----
----
Less:Minority Profit
-9.38%2.43M
-35.00%1.35M
-54.90%640.12K
237.57%2.49M
--2.68M
--2.08M
--1.42M
--738.11K
----
----
Net profit of parent company owners
-53.74%125.12M
-62.08%92.38M
-67.89%49.91M
-21.81%297.34M
0.29%270.48M
59.70%243.59M
192.03%155.45M
161.05%380.3M
127.10%269.7M
114.31%152.53M
Earning per share
Basic earning per share
-66.90%1.399
-72.97%1.03
-67.90%0.78
-38.08%4.65
-24.78%4.2262
19.81%3.81
118.92%2.43
147.04%7.51
--5.6188
114.86%3.18
Diluted earning per share
-66.90%1.399
-72.97%1.03
-67.90%0.78
-38.08%4.65
-24.78%4.2262
19.81%3.81
118.92%2.43
147.04%7.51
--5.6188
114.86%3.18
Other composite income
157.10%15.37K
-9.3K
-13.05K
-4.26K
-26.92K
0
0
Other composite income of parent company owners
157.10%15.37K
---9.3K
---13.05K
---4.26K
---26.92K
----
----
--0
--0
----
Total composite income
-53.30%127.56M
-61.85%93.72M
-67.78%50.54M
-21.31%299.83M
1.27%273.13M
61.06%245.66M
194.70%156.87M
161.55%381.03M
127.10%269.7M
114.31%152.53M
Total composite income of parent company owners
-53.73%125.14M
-62.08%92.37M
-67.90%49.9M
-21.81%297.34M
0.28%270.45M
59.70%243.59M
192.03%155.45M
161.05%380.3M
127.10%269.7M
114.31%152.53M
Total composite income of minority owners
-9.38%2.43M
-35.00%1.35M
-54.90%640.12K
237.57%2.49M
--2.68M
--2.08M
--1.42M
--738.11K
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -36.31%602.08M-48.79%382.17M-60.02%192.09M-20.70%1.12B-6.81%945.3M32.58%746.29M131.85%480.44M113.64%1.42B123.64%1.01B106.31%562.9M
Operating revenue -36.31%602.08M-48.79%382.17M-60.02%192.09M-20.70%1.12B-6.81%945.3M32.58%746.29M131.85%480.44M113.64%1.42B123.64%1.01B106.31%562.9M
Other operating revenue -----39.23%667.27K----14.87%3.01M----22.43%1.1M----84.66%2.62M----344.78%896.89K
Total operating cost -28.75%507.04M-39.37%317.01M-51.79%149M-15.03%870.69M-2.12%711.63M29.99%522.86M104.41%309.05M94.67%1.02B115.94%727.03M97.40%402.22M
Operating cost -42.13%293.84M-54.12%184.57M-63.59%92.69M-26.82%604.52M-16.67%507.73M21.80%402.26M112.62%254.54M119.70%826.09M155.44%609.29M135.54%330.26M
Operating tax surcharges 23.67%6.8M-60.40%1.84M-82.46%612.12K-25.60%6.43M-1.64%5.5M73.95%4.66M361.29%3.49M114.45%8.64M56.57%5.59M0.72%2.68M
Operating expense 1.65%77.97M3.64%48.41M2.96%20.72M24.55%106.61M34.72%76.7M36.32%46.71M45.57%20.13M22.06%85.59M21.78%56.93M18.05%34.27M
Administration expense 33.72%43.29M57.38%30.18M33.17%11.45M-16.35%40.28M30.98%32.37M24.57%19.18M72.34%8.59M79.06%48.15M38.89%24.72M27.58%15.4M
Financial expense -38.93%-5.5M-12.77%-6.15M-157.90%-1.6M75.19%-4.11M68.59%-3.96M-13.70%-5.46M233.95%2.76M-1,631.63%-16.58M-1,953.29%-12.61M-763.44%-4.8M
-Interest expense (Financial expense) 122.35%2.32M-17.92%587.36K-18.19%292.89K192.57%1.36M195.13%1.04M527.67%715.63K759.50%358.02K135.82%463.67K136.48%353.6K8.98%114.01K
-Interest Income (Financial expense) -91.46%-7.13M-87.56%-4.72M-10.25%-1.48M-16.09%-6.18M-163.74%-3.73M-179.80%-2.52M-451.24%-1.34M-72.14%-5.33M43.94%-1.41M51.65%-898.98K
Research and development -2.84%90.64M4.75%58.15M28.63%25.13M60.54%116.98M116.44%93.29M127.34%55.51M76.35%19.54M50.92%72.86M40.64%43.1M20.01%24.42M
Credit Impairment Loss 33.83%-1.82M134.08%769.24K76.98%-475.48K39.31%-2.29M17.01%-2.75M-176.10%-2.26M-132.73%-2.07M-1,477.15%-3.77M-1,441.39%-3.31M-280.71%-817.61K
Asset Impairment Loss ---876.46K---854.4K-------10.23M--------------0--------
Other net revenue -31.59%51.52M-33.91%37.8M2.99%12.59M90.53%86.08M224.94%75.32M287.34%57.2M148.88%12.23M61.86%45.18M19.02%23.18M26.08%14.77M
Fair value change income --1.95M--118K--118K----------------------------
Invest income -1.88%39.11M-13.65%26.01M-39.75%6.28M287.23%57.17M351.91%39.86M350.21%30.12M259.70%10.42M74.45%14.76M50.33%8.82M79.45%6.69M
-Including: Investment income associates -----7.21%-173.88K-3.25%-246.11K-111.55%-304.26K-106.57%-172.99K-109.75%-162.18K-143.98%-238.35K13.88%2.63M--2.63M29.36%1.66M
Asset deal income -58.13%199.81K-53.33%203.52K-155.09%-37.86K2,206.59%477.21K2,206.59%477.21K3,380.57%436.11K--68.73K--20.69K--20.69K--12.53K
Other revenue -65.67%12.95M-60.02%11.56M76.31%6.71M19.86%40.95M113.77%37.73M225.39%28.9M31.07%3.81M73.54%34.17M27.68%17.65M8.33%8.88M
Operating profit -52.57%146.57M-63.31%102.96M-69.68%55.67M-22.48%337.81M-0.51%308.99M59.96%280.63M201.32%183.62M165.72%435.79M127.70%310.58M117.12%175.44M
Add:Non operating Income 200.04%173.95K-72.41%15.9K-77.62%12.9K-85.00%107.43K-91.11%57.97K-91.16%57.64K-72.69%57.64K718.40%716.11K2,269.00%651.8K61,982.49%651.8K
Less:Non operating expense -43.26%1.82M-88.52%348.31K-97.79%54.21K174.42%3.88M471.84%3.21M455.12%3.03M1,742.59%2.46M522.00%1.42M901.13%561.51K170,826,156.25%546.64K
Total profit -52.62%144.92M-63.04%102.63M-69.30%55.63M-23.23%334.03M-1.56%305.83M58.16%277.66M197.00%181.22M165.52%435.09M127.81%310.67M117.25%175.55M
Less:Income tax cost -46.84%17.37M-72.17%8.9M-79.15%5.08M-36.74%34.2M-20.24%32.68M38.98%31.99M212.74%24.36M197.33%54.06M132.64%40.97M138.98%23.02M
Net profit -53.31%127.55M-61.85%93.72M-67.77%50.55M-21.31%299.83M1.28%273.15M61.06%245.66M194.70%156.87M161.55%381.03M127.10%269.7M114.31%152.53M
Net profit from continuing operation -53.31%127.55M-61.85%93.72M-67.77%50.55M-21.31%299.83M1.28%273.15M61.06%245.66M194.70%156.87M161.55%381.03M127.10%269.7M114.31%152.53M
Net income from discontinuing operating ----------------------0----------------
Less:Minority Profit -9.38%2.43M-35.00%1.35M-54.90%640.12K237.57%2.49M--2.68M--2.08M--1.42M--738.11K--------
Net profit of parent company owners -53.74%125.12M-62.08%92.38M-67.89%49.91M-21.81%297.34M0.29%270.48M59.70%243.59M192.03%155.45M161.05%380.3M127.10%269.7M114.31%152.53M
Earning per share
Basic earning per share -66.90%1.399-72.97%1.03-67.90%0.78-38.08%4.65-24.78%4.226219.81%3.81118.92%2.43147.04%7.51--5.6188114.86%3.18
Diluted earning per share -66.90%1.399-72.97%1.03-67.90%0.78-38.08%4.65-24.78%4.226219.81%3.81118.92%2.43147.04%7.51--5.6188114.86%3.18
Other composite income 157.10%15.37K-9.3K-13.05K-4.26K-26.92K00
Other composite income of parent company owners 157.10%15.37K---9.3K---13.05K---4.26K---26.92K----------0--0----
Total composite income -53.30%127.56M-61.85%93.72M-67.78%50.54M-21.31%299.83M1.27%273.13M61.06%245.66M194.70%156.87M161.55%381.03M127.10%269.7M114.31%152.53M
Total composite income of parent company owners -53.73%125.14M-62.08%92.37M-67.90%49.9M-21.81%297.34M0.28%270.45M59.70%243.59M192.03%155.45M161.05%380.3M127.10%269.7M114.31%152.53M
Total composite income of minority owners -9.38%2.43M-35.00%1.35M-54.90%640.12K237.57%2.49M--2.68M--2.08M--1.42M--738.11K--------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data